Hepatitis B Virus Vaccines
Research results from University of Colorado, Colorado Health Sciences Center update understanding of hepatitis B virus vaccines
Published in Vaccine Weekly, March 10th, 2010
Research findings, 'HBIg discontinuation with maintenance oral anti-viral therapy and HBV vaccination in liver transplant recipients,' are discussed in a new report. According to a study from the United States, "Hepatitis B (HBV) is an uncommon indication for liver transplantation in the US accounting for approximately 5% of cases. Recurrence prophylaxis is typically long-term hepatitis B immune-globulin (HBIg) and an oral anti-HBV agent."
"Because of high HBIg costs and improving efficacy of new oral agents, there is increasing interest in HBIg discontinuation. To describe results of a protocol at our center including HBV vaccination and HBIg discontinuation. All...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2010-03-10)
More Articles from Vaccine Weekly
- Wiley-Blackwell
Hepatitis B and C remain public health issue -- up to 5.3 million Americans infected - Bacillus Anthracis
Research on Bacillus anthracis described by J. Kern and colleagues - Bordetella
Study data from J.J. Gisel and colleagues update understanding of Bordetella - CEL-SCI Corporation
CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression of Rheumatoid Arthritis - Gene Therapy
Research results from R. Pilankatta and co-authors update knowledge of gene therapy - Hepatitis B Virus
Research conducted at X. Causse and co-authors has provided new information about hepatitis B virus - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
